571 related articles for article (PubMed ID: 12829150)
1. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas.
DeLaney TF; Spiro IJ; Suit HD; Gebhardt MC; Hornicek FJ; Mankin HJ; Rosenberg AL; Rosenthal DI; Miryousefi F; Ancukiewicz M; Harmon DC
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1117-27. PubMed ID: 12829150
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.
Kraybill WG; Harris J; Spiro IJ; Ettinger DS; DeLaney TF; Blum RH; Lucas DR; Harmon DC; Letson GD; Eisenberg B;
J Clin Oncol; 2006 Feb; 24(4):619-25. PubMed ID: 16446334
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas.
Mullen JT; Kobayashi W; Wang JJ; Harmon DC; Choy E; Hornicek FJ; Rosenberg AE; Chen YL; Spiro IJ; DeLaney TF
Cancer; 2012 Aug; 118(15):3758-65. PubMed ID: 22180344
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant and adjuvant chemotherapy with modified mesna, adriamycin, ifosfamide, and dacarbazine (MAID) regimen for adult high-grade non-small round cell soft tissue sarcomas.
Ogura K; Goto T; Imanishi J; Shinoda Y; Okuma T; Tsuda Y; Kobayashi H; Akiyama T; Hirata M; Yamamoto A; Kawano H
Int J Clin Oncol; 2013 Feb; 18(1):170-6. PubMed ID: 22179493
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
Edmonson JH; Petersen IA; Shives TC; Mahoney MR; Rock MG; Haddock MG; Sim FH; Maples WJ; O'Connor MI; Gunderson LL; Foo ML; Pritchard DJ; Buckner JC; Stafford SL
Cancer; 2002 Feb; 94(3):786-92. PubMed ID: 11857314
[TBL] [Abstract][Full Text] [Related]
6. Has "MAID" made it in the management of high-risk soft-tissue sarcoma?
O'Sullivan B; Bell RS
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):915-6. PubMed ID: 12829123
[No Abstract] [Full Text] [Related]
7. Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity: Improved Efficacy and Reduced Toxicity.
Chowdhary M; Sen N; Jeans EB; Miller L; Batus M; Gitelis S; Wang D; Abrams RA
Am J Clin Oncol; 2019 Jan; 42(1):1-5. PubMed ID: 29782358
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.
Bui BN; Chevallier B; Chevreau C; Krakowski I; Peny AM; Thyss A; Maugard-Louboutin C; Cupissol D; Fargeot P; Bonichon F
J Clin Oncol; 1995 Oct; 13(10):2629-36. PubMed ID: 7595717
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
Huang YH; Wen XP; Hu L
Ai Zheng; 2002 Aug; 21(8):907-9. PubMed ID: 12478905
[TBL] [Abstract][Full Text] [Related]
10. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
Elias A; Ryan L; Sulkes A; Collins J; Aisner J; Antman KH
J Clin Oncol; 1989 Sep; 7(9):1208-16. PubMed ID: 2504890
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study.
Look Hong NJ; Hornicek FJ; Harmon DC; Choy E; Chen YL; Yoon SS; Nielsen GP; Szymonifka J; Yeap BY; DeLaney TF; Mullen JT
Eur J Cancer; 2013 Mar; 49(4):875-83. PubMed ID: 23092789
[TBL] [Abstract][Full Text] [Related]
12. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
Zhao J; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of metastatic soft tissue sarcoma with a combination of adriamycin and DTIC or adriamycin and ifosfamide.
Weh HJ; Zügel M; Wingberg D; Schwarz R; Zornig C; Dietel M; Hossfeld DK
Onkologie; 1990 Dec; 13(6):448-52. PubMed ID: 2128712
[TBL] [Abstract][Full Text] [Related]
14. Determinants of toxicity, patterns of failure, and outcome among adult patients with soft tissue sarcomas of the extremity and superficial trunk treated with greater than conventional doses of perioperative high-dose-rate brachytherapy and external beam radiotherapy.
San Miguel I; San Julián M; Cambeiro M; Fernández Sanmamed M; Vázquez-García B; Pagola M; Gaztañaga M; Martín-Algarra S; Martinez-Monge R
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e529-39. PubMed ID: 21665380
[TBL] [Abstract][Full Text] [Related]
15. Feasibility study of postoperative adjuvant chemotherapy and radiotherapy for soft-tissue sarcoma.
Fuchs R; Schadeck-Gressel C; Makoski HB; von Andrian-Werburg HF; Knieriem HJ; Westerhausen M
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S199-203. PubMed ID: 8453698
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
Pappo AS; Devidas M; Jenkins J; Rao B; Marcus R; Thomas P; Gebhardt M; Pratt C; Grier HE
J Clin Oncol; 2005 Jun; 23(18):4031-8. PubMed ID: 15767644
[TBL] [Abstract][Full Text] [Related]
17. Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients.
Wang B; Yu X; Xu S; Xu M
Medicine (Baltimore); 2016 Jan; 95(4):e2611. PubMed ID: 26825914
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus Ifosfamide.
Palassini E; Ferrari S; Verderio P; De Paoli A; Martin Broto J; Quagliuolo V; Comandone A; Sangalli C; Palmerini E; Lopez-Pousa A; De Sanctis R; Bottelli S; Libertini M; Picci P; Casali PG; Gronchi A
J Clin Oncol; 2015 Nov; 33(31):3628-34. PubMed ID: 26351345
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.
Kraybill WG; Harris J; Spiro IJ; Ettinger DS; DeLaney TF; Blum RH; Lucas DR; Harmon DC; Letson GD; Eisenberg B
Cancer; 2010 Oct; 116(19):4613-21. PubMed ID: 20572040
[TBL] [Abstract][Full Text] [Related]
20. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
